⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19799223 | 1.00 | — | — | |
| SCHEMBL2209309 | 1.00 | — | — | |
| SCHEMBL4104111 | 0.84 | — | — | |
| SCHEMBL15606961 | 0.83 | — | — | |
| SCHEMBL18631085 | 0.78 | — | — | |
| SCHEMBL16714237 | 0.78 | — | — | |
| SCHEMBL10618646 | 0.78 | — | — | |
| SCHEMBL20136864 | 0.78 | — | — | |
| SCHEMBL16129794 | 0.74 | — | — | |
| SCHEMBL20550863 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4504711-A2 | IONIZABLE LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | Sunvax MRNA Therapeutics Inc. (US) | 2025-02-12 | — | — | EP | disclosed |
| CN-119325466-A | Ionizable lipid compounds and lipid nanoparticle compositions | 尚威天成信使核糖核酸治疗公司 | 2025-01-17 | — | — | CN | disclosed |
| US-20230322689-A1 | IONIZABLE LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | SunVax mRNA Therapeutics Inc. (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230322689-A1 | IONIZABLE LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | SunVax mRNA Therapeutics Inc. (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230322689-A1 | IONIZABLE LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | SunVax mRNA Therapeutics Inc. (US) | 2023-10-12 | — | — | US | disclosed |
| WO-2023196527-A2 | IONIZABLE LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | SunVax mRNA Therapeutics Inc. (US) | 2023-10-12 | — | — | WO | disclosed |
| US-11708384-B2 | Systems and methods for mechanosynthesis | CBN NANO TECHNOLOGIES INC. (CA) | 2023-07-25 | — | — | US | disclosed |
| US-11592463-B2 | Systems and methods for mechanosynthesis | CBN NANO TECHNOLOGIES INC. (CA) | 2023-02-28 | — | — | US | disclosed |
| US-20220106338-A1 | Systems and Methods for Mechanosynthesis | CBN NANO TECHNOLOGIES INC. (CA) | 2022-04-07 | — | — | US | disclosed |
| EP-3954649-A1 | IMPROVED SYSTEMS AND METHODS FOR MECHANOSYNTHESIS | CBN Nano Technologies Inc. (CA) | 2022-02-16 | — | — | EP | disclosed |
| US-20080210858-A1 | High Stability Polyionic Liquid Salts | SIGMA-ALDRICH CO. NEWCO INC. | 2008-09-04 | — | — | US | disclosed |
| WO-2008095069-A2 | HIGH STABILITY POLYIONIC LIQUID SALTS | SIGMA-ALDRICH CO. (US) | 2008-08-07 | — | — | WO | disclosed |
| WO-2008095069-A2 | HIGH STABILITY POLYIONIC LIQUID SALTS | SIGMA-ALDRICH CO. (US) | 2008-08-07 | — | — | WO | disclosed |
| US-20070176540-A1 | Transition metal complex compound and organic electroluminescence device using the compound | IDEMITSU KOSAN CO., LTD. (JP) | 2007-08-02 | — | — | US | disclosed |
| US-20070176540-A1 | Transition metal complex compound and organic electroluminescence device using the compound | IDEMITSU KOSAN CO., LTD. (JP) | 2007-08-02 | — | — | US | disclosed |
| US-20060183870-A1 | Heterodiamondoids | CHEVRON U.S.A. INC. | 2006-08-17 | — | — | US | disclosed |
| US-7049374-B2 | Heterodiamondoids | CHEVRON U.S.A. INC. (US) | 2006-05-23 | — | — | US | disclosed |
| EP-1542983-A1 | HETERODIAMONDOIDS | Chevron U.S.A. Inc. (US) | 2005-06-22 | — | — | EP | disclosed |
| US-20040059145-A1 | Heterodiamondoids | CHEVRON USA INC. | 2004-03-25 | — | — | US | disclosed |
| WO-2004009577-A1 | HETERODIAMONDOIDS | CHEVRON U.S.A. INC. (US) | 2004-01-29 | — | — | WO | disclosed |